Skip to content
Recall Observatory FDA recall evidence

Drug product

Irinotecan Hydrochloride Injection, USP, 40 mg/2 mL (20 mg/mL), 2 mL Single-Dose Vial, Rx Only, Distributed by: Areva Pharmaceuticals, Inc., Gerogetown, IN 47122, Made in India, NDC 59923-714-02.

D-0270-2021

November 19, 2020

Class II

Product summary

Firm
Areva Pharmaceuticals Inc
Event
Event 87363
Status
Terminated
Classification
Class II
Quantity
3287 vials
Official record key
drug-enforcement:D-0270-2021

Official wording

Reason: CGMP Deviations: based on a Warning Letter received by the manufacturer of the recalled product for inadequate out-of specification investigations, complaint and the investigation conclusions.

Code information: Lot 7S10022A, Exp Jan-21

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations